Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DABRAFENIB vs DACARBAZINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DABRAFENIB vs DACARBAZINE: Safety Overview

Metric DABRAFENIB DACARBAZINE
Total FAERS Reports 19,305 5,105
Deaths Reported 4,165 847
Death Rate 21.6% 16.6%
Hospitalizations 5,325 1,914
Average Patient Age 58.3 yrs 45.5 yrs
% Female Patients 48.0% 47.8%
FDA Approval Date Mar 16, 2023 Approved Prior to Jan 1, 1982
Manufacturer Novartis Pharmaceuticals Corporation Fresenius Kabi USA, LLC
Route ORAL INTRAVENOUS
Marketing Status Prescription Discontinued